PIXEN
Live / Allowed — Notice of allowance issued (as of 14 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Jun 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98621739
- Mark type
- Stylized text
- Filed
- 27 Jun 2024
- Published for opposition
- 19 Aug 2025
- Attorney of record
- Aaron Y. Silverstein
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable software for managing the commercialization of biotechnology, pharmaceutical, life sciences, and biopharma products and services; Downloadable software for organizing and managing biotechnology, pharmaceutical, life sciences, and biopharma product development; Downloadable software for valuation of biotechnology, pharmaceutical, life sciences, and biopharma products and services; Downloadable software for competitive analysis of biotechnology, pharmaceutical, life sciences, and biopharma companies, products and services; Downloadable software for analyzing biotechnology, pharmaceutical, life sciences, and biopharma industry news; Downloadable software for analyzing market events that affect valuations of products, services, and companies; Downloadable software for conducting and managing clinical trials
- Class 035 — Advertising and business services: Analyzing and compiling business data; Business assistance, advisory and consulting services in the field of pharmaceuticals; Business assistance, advisory and consulting services in the field of biotechnology; Business assistance, advisory and consulting services in the field of life sciences; Business assistance, advisory and consulting services in the field of biopharma; Business assistance, advisory and consulting services in the field of clinical trials; Business consulting services; Business data research; Data processing services; Data processing services in the field of biotechnology; Data processing services in the field of pharmaceuticals; Data processing services in the field of life sciences; Data processing services in the field of biopharma; Data processing services in the field of clinical trials
- Class 042 — Scientific and technological services: Data mining; Providing on-line non-downloadable software for managing the commercialization of biotechnology, pharmaceutical, life sciences, and biopharma products and services; Providing on-line non-downloadable software for organizing and managing biotechnology, pharmaceutical, life sciences, and biopharma product development; Providing on-line non-downloadable software for valuation of biotechnology, pharmaceutical, life sciences, and biopharma products and services; Providing on-line non-downloadable software for competitive analysis of biotechnology, pharmaceutical, life sciences, and biopharma companies, products and services; Providing on-line non-downloadable software for analyzing biotechnology, pharmaceutical, life sciences, and biopharma industry news; Providing on-line non-downloadable software for analyzing market events that affect valuations of products, services, and companies; Providing on-line non-downloadable software for conducting and managing clinical trials
Owner
- IWISDOM BIO, LLC, Dover, DE, US
- IWISDOM BIO, LLC, Dover, DE, US
Prosecution history
- 14 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Aug 2025 — PUBLISHED FOR OPPOSITION
- 13 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Jun 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 03 Apr 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 03 Apr 2025 — FINAL REFUSAL E-MAILED
- 03 Apr 2025 — FINAL REFUSAL WRITTEN
- 20 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED